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In this study we investigated the accumulation of dose to a deforming anatomy such as lung based
on voxel tracking and by using time weighting factors derived from a breathing probability distri-
bution function p.d.f.. A mutual information registration scheme using thin-plate spline warping
provided a transformation that allows the tracking of points between exhale and inhale treatment
planning datasets and/or intermediate state scans. The dose distributions were computed at the
same resolution on each dataset using the Dose Planning Method DPM Monte Carlo code. Two
accumulation/interpolation approaches were assessed. The first maps exhale dose grid points onto
the inhale scan, estimates the doses at the “tracked” locations by trilinear interpolation and scores
the accumulated doses via the p.d.f. on the original exhale data set. In the second approach, the
“volume” associated with each exhale dose grid point exhale dose voxel is first subdivided into
octants, the center of each octant is mapped to locations on the inhale dose grid and doses are
estimated by trilinear interpolation. The octant doses are then averaged to form the inhale voxel
dose and scored at the original exhale dose grid point location. Differences between the interpola-
tion schemes are voxel size and tissue density dependent, but in general appear primarily only in
regions with steep dose gradients e.g., penumbra. Their magnitude small regions of few percent
differences is less than the alterations in dose due to positional and shape changes from breathing
in the first place. Thus, for sufficiently small dose grid point spacing, and relative to organ motion
and deformation, differences due solely to the interpolation are unlikely to result in clinically
significant differences to volume-based evaluation metrics such as mean lung dose MLD and
tumor equivalent uniform dose gEUD. The overall effects of deformation vary among patients.
They depend on the tumor location, field size, volume expansion, tissue heterogeneity, and direction
of tumor displacement with respect to the beam, and are more likely to have an impact on serial
organs such as esophagus, rather than on large parallel organs such as lung. © 2005 American
Association of Physicists in Medicine. DOI: 10.1118/1.1949749Key words: organ deformation, 4D treatment planning, grid size, dose calculationI. INTRODUCTION
Motion and deformation induced in human tissue by ventila-
tory motion can be a major issue in radiation therapy as the
standard treatment planning is usually based on a single
computed tomography CT scan and hence one instance of
the patient’s anatomy. Even if the planning CT images are
free of motion artifacts1 the interfraction movement that oc-
curs due to physiological processes within time scales
shorter than the delivery of one treatment fraction leads to
differences between the planned and delivered dose distribu-
tions during a fractionated treatment regimen.2,3 Due to the
influence of these differences on tumors and normal tissues,
the tumor control probabilities TCPs and normal tissue
complication probabilities NTCPs are likely to be impacted
in the face of organ motion.4 Moreover, as the recent ad-
vances in radiation therapy provide improved target delinea-
tion and dose calculation methods, dose distributions are of-
ten designed to conform more closely to the targets and the
uncertainties associated with organ motion become more ap-
parent. This may limit the success of the conformal radio-
therapy thereby leading to local control failure and/or normal
2487 Med. Phys. 32 „8…, August 2005 0094-2405/2005/32„8tissue complications. It is thus not only desirable, but also
necessary to generate, prior to treatment, dose distributions
that include the effects of the treatment geometric uncertain-
ties by using the time-varying anatomical information in or-
der to reduce the planning target volume PTV Ref. 5
margins.6
The development of methods for incorporating the effect
of geometric uncertainties in the dose distribution has been
the subject of significant research effort in the past years. An
early approach to evaluate the consequences of organ motion
on delivered doses was the convolution2,3,7–12 of the static
dose distribution that would result without motion with a
kernel that describes the motion characteristics.2 The inher-
ent assumptions of this method—rigid body anatomy and
invariance of the dose distribution under small
displacements—limit its usefulness. With the emergence of
Monte Carlo as a tool for dose calculation, dose convolution
evolved to fluence convolution13,14 which correctly models
the changes in doses due to tissue density variation, while
still assuming rigid body motion. Although fluence convolu-
tion provides useful information regarding alterations in tar-
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deformations,15 dose calculation for the surrounding normal
tissues based upon a rigid organ model remains questionable.
Consequently there is a need for deformable patient models
in regions such as the lung.
A required step toward the estimation of the doses in a
deforming anatomy is to establish a correlation between vox-
els from various representations of the anatomy during radia-
tion delivery. This correlation makes it possible to accumu-
late dose on a single system of coordinates e.g., the planning
CT data set for plan evaluation. Research continues into the
use of image registration techniques to provide nonrigid
body voxel mapping between CT’s acquired over various
segments of the ventilatory cycle, such as those that incor-
porate spline transformation models16–18 and mutual
information19,20 as similarity criterion. Several studies have
already investigated the effect of organ deformation on cu-
mulative doses delivered by high energy photon beams in
liver21 and prostate22 and by heavy-ion therapy in lung.23 In
these studies, the dose grid points from the planning CT are
mapped on various breathing phase CT’s; the doses at the
tracked grid point locations are assumed to be the estimators
of the doses received by the planning grid point at a given
respiratory phase. However, the validity of this assumption
has not been yet investigated.
In the present study we report on the implementation of
dose reconstruction in a deforming anatomy based on voxel
tracking and by using time weighting factors derived from a
breathing probability distribution function. We investigate
the validity and the clinical implications of our approach, for
example, lung cancer treatment plans.
II. METHODS AND MATERIALS
A. Patient data collection
Under a protocol approved by the Internal Review Board
at the University of Michigan, data were acquired for six
patients diagnosed with inoperable nonsmall cell lung can-
cer. Four patients A, B, C, D had tumors with volume
100 cm3, apical, midlateral and midmedial, respectively,
whereas patients E and F had larger tumors 150+cm3 lo-
cated inferior and mediastinal. Patient B was different from
the other patients in that the tumor was located in the prox-
imity of the esophagus to the extent that in some regions
PTV and esophagus overlapped. The center of the mass of
the tumor displacements along the three axes and the com-
bined right and left lung volumes at exhale and inhale are
compiled in Table I in order to provide the reader with some
information regarding the extent of motion underwent by the
tumors and lungs.
CT scans were acquired at normal exhale and inhale states
during coached voluntary breath hold. Both exhale and in-
hale scans were obtained sequentially in the same session in
order to eliminate any offset between the two data sets due to
setup errors. The scans were acquired using a helical CT
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5 mm aperture and a pitch of 2. For all patients, treatment
plans were designed on the exhale data set; the exhale PTV
was formed by a uniform 1 cm expansion of the clinical
tumor volume CTV.
B. Distorted datasets
In order to be able to build a deformable model of the
patient, CT datasets obtained at exhale reference and inhale
homologous needed to be registered. To achieve this, we
used a thin-plate transformation model available within our
in-house treatment planning system UMPlan.16 In brief,
control points were placed manually on the reference and
homologous image dataset, the homologous points were it-
eratively manipulated by the Nelder-Mead simplex algorithm
and the homologous point configuration that maximizes the
mutual information of the two image datasets was selected as
the optimal transformation between the two datasets.
This approach had been used previously24–26 to map, with
sufficient degree of accuracy, the liver or the right lung be-
tween two CT scans acquired at different breathing phases
for the same patient. In the current study we manually placed
46 control points on the reference exhale and the homolo-
gous inhale dataset in order to provide sufficient degrees of
freedom. The points were distributed in the whole thorax and
were placed on the tumor and lungs surfaces, in the vicinity
of bony structures ribs and in the interior of the lung, in
places that could be easily identified on both scans. Visual
inspection of the deformed images for the lung cases showed
the process to be quite adequate for planning purposes, but
not perfect. This was expected considering that the thin-plate
spline transformation only handles the global deformations.16
Therefore, we replaced the inhale images with an “inhale
phantom” created by using the transformation provided by
the registration between the real exhale and inhale datasets—
the intent here being to avoid the registration bias in the
comparisons between the two dose reconstruction methods
described below. Figure 1 shows an example of registration
exhale and the “inhale phantom,” along with the correspond-
ing joint histogram. The histogram axes represent the pos-
TABLE I. The center of the mass of the tumor displacements along the
left-right LR, anterior-posterior AP, and superior-inferior SI directions
and the combined right and lung volumes at exhale and inhale. Negative




Combined right and left lung
volumes cc
LR AP SI Exhale Inhale
A 0.2 −0.6 1.3 3813 4650
B −0.1 −0.3 0.3 4571 5690
C −0.2 −1.3 0.1 3623 4049
D 0.1 −0.2 −1.0 5385 5852
E −0.6 0.3 −1.6 5667 6142
F −0.7 −1.2 −0.3 2884 3798sible gray scale values in the reference I1 and homologous
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pair I1x ,y / I2x ,y occurs in the pair of images, where x ,y
are the coordinates of the pixels in each image; thus the
histogram is highly focused in perfectly aligned images and
the dispersion grows when images are misaligned. The lung
tissue densities in the “inhale phantom” were scaled accord-
ingly, so that the total mass of the lung was conserved. For
the remaining of the paper the term “inhale” will refer to the
“inhale phantom” image dataset.
C. Monte Carlo treatment planning
One major concern in terms of the dose calculation algo-
rithms used in treatment planning is how the tissue hetero-
geneities are handled, especially in sites such as lung. Thus
far, Monte Carlo based algorithms are known to provide the
most accurate dose calculation, being limited only by the
accuracy of their inputs. At our institution, a virtual source
model27,28 developed for Monte Carlo treatment planning
RTDPM using the Dose Planning Method Monte Carlo
code system29 has been integrated within our in-house treat-
ment planning system, UMPlan University of Michigan,
Ann Arbor, MI. RTDPM was used for all treatment plan-
ning calculations in this study. The typical treatment plan
beam configuration consisted of conformal 6 /15 MV ante-
rior, lateral, and oblique fields, combined with segmental
fields directed from the same angles to produce a dose dis-
tribution of 100±5% within the planning target volume
PTV. The average number of beams per plan was 5 range
3–7. All plans were normalized to 100% at the isocenter. We
used a 2 mm step size, and low energy electron and photon
cut-off values of 200 and 10 keV, respectively. For each
treatment plan, approximately one billion histories per field
were simulated, resulting in 1- statistics of better than 1.0%
on average within the PTV. Statistical uncertainties for the
normal lung tissue, generally located in the low dose region,
were typically between 1% and 5.0%, however, volume in-
dices, such as MLD and NTCP are relatively insensitive to
even larger point dose uncertainties. The statistical uncer-
tainty in the irradiated region varies approximately as the
square root of dose.
The conformal plans beam arrangement and monitor
units initially designed on the reference dataset i.e., exhale
were also used for the calculation of the dose distribution on
the inhale dataset at the same dose grid resolution. The dose
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for the purpose of assessing the grid size effects on the in-
terpolation methods proposed for dose reconstruction as de-
scribed in next section.
In addition to comparing the results from the two interpo-
lation schemes on the deformed inhale doses for various grid
sizes, we compared the dose calculated on the static exhale
dataset with the deformed dose from the inhale datasets, as
well as with the cumulative doses, using a grid size of
3.5 mm in order to minimize the grid size effects.
DVHs for the uninvolved lung i.e., both lungs minus
tumor served as input for the calculation of the mean lung
dose MLD, and the gEUD Ref. 30 to tumor was evalu-
ated using an a parameter value of −10, which assumes a
moderately aggressive tumor.
D. Dose reconstruction
The basic idea for dose reconstruction was to track dose
grid voxels between exhale and inhale using the transforma-
tion provided by the registration technique, to obtain an es-
timate of the dose received at inhale by each exhale voxel
and to accumulate this dose back onto the exhale voxel.
In Monte Carlo based calculation algorithms, the dose at
each grid point is the average energy deposited into a cubical
volume voxel centered at the grid point. The simplest esti-
mate of the dose received by the exhale voxel at inhale
which we will call Method 1, a direct approximation was
obtained by mapping the center of the exhale voxel onto the
inhale dose grid and by computing the dose at the tracked
location by trilinear interpolation of the doses at the closest
neighboring dose grid points as shown in Fig. 2a note that
only the two-dimensional case is shown for clarity. If there
is no voxel expansion at inhale dashed square, the dose at
the tracked center is still likely representative of the energy
deposited in the voxel transposed from exhale. However, in
the event that after transposition, the exhale voxel expands
across several inhale grid points voxels which happen to fall
in the high dose gradient regions, the dose at the tracked
exhale voxel center may no longer be representative of the
energy deposited in the expanded voxel, as there are inhale
grid points falling into the expanded voxel that are not ac-
counted for such as grid points e and f in Fig. 2a. We
have therefore refined the interpolation method Method 2, a
FIG. 1. Thin-plate spline registration using mutual in-
formation as a similarity measure between the exhale
and the ”inhale phantom” and the corresponding joint
histogram; exhale and deformed inhale images are
shown together for comparison. The arrows point to-
ward regions of registration mismatches.refined approximation as depicted in Fig. 2b: the volume
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octants, the center of each octant is mapped to locations on
the inhale dose grid, doses at the tracked locations are esti-
mated by trilinear interpolation, and their average values are
scored at the original exhale dose grid point locations.
Accumulation of doses in the deforming dataset was per-
formed by applying time weighting factors representing the
relative amount of time spent at a particular breathing phase
derived from a breathing probability distribution function,
Dreci = 
k
wk · Dki , 1
where Dreci is the cumulative dose in the exhale voxel i, k
the breathing phase, Dki the dose received by exhale voxel
i at the breathing phase k, wk the time weighting coefficient
at breathing stage k. As for these investigations, where only
the exhale and inhale breathing phases were used, weighting
factors of w1=70% and w2=30% were assigned to be repre-
sentative of the relative times spent at those two positions,
respectively. These weighting coefficients were derived
based on the breathing function originally proposed by Lujan
et al.2 and shown to be a good approximation for many
31,32
FIG. 2. Two interpolation approaches for estimating the dose received at
inhale by each exhale voxel only the two-dimensional case is shown for
clarity: a Method 1, direct approximation, the center C of the exhale voxel
is mapped at location C onto the inhale dose grid and the dose at C is
estimated by the trilinear interpolation of the doses at the closest neighbor-
ing dose grid points a, b, c, d. If the exhale voxel expands at inhale, inhale
dose grid points such as e and f that fall into the inhale voxel are not
accounted for when dose at C is calculated by trilinear interpolation; b
Method 2, refined approximation, the volume associated with each exhale
voxel is first sub-divided into octants, the center of each octant 1,2,3,4 is
mapped to locations on the inhale dose grid 1 ,2 ,3 ,4, doses at the
tracked locations are estimated by trilinear interpolation and their average
value is scored at the original exhale dose grid point location.patients.
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In order to better understand the differences between the
reconstructed dose that accounts for the motion/deformation
effects which inherently include patient shape e.g., skin
surface and tissue density changes induced by ventilation
and the original dose distribution planned on the exhale scan,
we first analyzed the changes in the inhale dose from the
exhale dose. To this end, we decomposed the changes in
inhale dose D into two components as follows Fig. 3:
for an exhale voxel centered at rexhale in some arbitrary ref-
erence system that moves to rinhale in the same reference
frame, a change in dose D1 at a point in space due to
changes in patient shape and tissue density alterations, and a
change in dose D2 due to the voxel displacement with re-
spect to the beam due to translational motion and/or defor-
mation.
III. RESULTS
A. Grid size effects
For a given grid size, the dose difference displays be-
tween the inhale dose distributions scored on the exhale
planning dataset as predicted by the two interpolation ap-
proaches described above reveal differences in the penum-
bral region, as it can be seen in the example shown in Fig.
4a here the calculation grid size was 5 mm. The magni-
tude of the differences between Methods 1 and 2 is influ-
enced by the choice of grid size, increasing from 2% to 6%
as the grid size increases from 3.5 mm to 10 mm. These dif-
ferences occur because the direct approximation Method 1
does not account for tracked points between inhale and ex-
hale occurring in the high dose gradient region. The profile
extracted along the yellow line Fig. 4b shows that differ-
ences tend to have larger magnitude in the higher density
tissue B due to sharper penumbral slope. Similar magnitude
differences between the two interpolation schemes were
found for the other five patients involved in this study.
While the differences between the two interpolation
schemes are only few percent for any given grid size, the
differences between calculations performed using a given in-
terpolation scheme but increasing grid size reveal larger dif-
ferences. They occur because as the grid size increases, the
interpolation tends to underestimate the dose in the upper
shoulder and overestimate the dose in the lower shoulder of
33
FIG. 3. The overall change in dose at inhale from exhale D can be decom-
posed in a change in dose D1 at a point in space due to patient shape and
tissue density changes and a change in dose D2 due to displacement with
respect to the beam.the profiles. These changes are reflected in the dose volume
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of Patient A. The use of a larger grid size 10 mm vs
3.5 mm shows an increase and decrease in the low dose and
high dose components of the DVH, respectively.
Table II shows a summary of various treatment metrics
used to assess the inhale doses mapped back on the exhale
dataset for tumor and normal lung for the 3.5 mm, 5 mm,
and 10 mm calculation grids and for both interpolation meth-
FIG. 4. a Dose difference display map between inhale dose distributions
mapped back on the exhale dataset as predicted by Method 2 and Method 1
for a 5 mm dose grid calculation positive/negative differences are indicated
in red/blue; b Dose profile extracted along the line AB shown in a.
FIG. 5. DVHs for the ipsilateral lung for one of the patients: black lines for
3.5 grid size, gray lines for 10.0 mm grid size, dashed lines for dose esti-
mated by Method 1, solid lines for dose estimated by Method 2.
Medical Physics, Vol. 32, No. 8, August 2005ods proposed for inhale dose scoring on the planning data
set, whereas Table III shows similar data for the esophagus
NTCPs for Patient B.
B. Impact of the breathing induced motion/
deformation on the inhale dose
Deviations in doses at inhale from the planning exhale
calculations were analyzed for all patients as described in
Sec. II E. Figures 6a–6c show an example of this type of
analysis for Patient A. Figure 6a shows changes in doses at
each point in space created by tissue density and patient
shape changes. In Fig. 6b hot/cold spots are created in re-
gions that move in/out of the radiation field and their mag-
nitude becomes larger as the displacement gets larger in this
case, the superior and inferior hot/cold spots have larger
magnitude than those in the anterior/posterior direction. The
overall changes in doses at inhale are large on the order of
30% as shown for Patient A in Fig. 6c and are primarily
due to voxel displacements with respect to the beams. The
changes in patient shape and tissue densities on one hand and
the displacement with respect to the beam on the other hand
may have competing effects as it can be seen in the dashed
circle area in Fig. 6 parts of the hot/cold spots in Fig. 6a
are canceled out by parts of the cold/hot spots from Fig.
6b.
Differences in the doses received by exhale voxels at the
inhale versus the exhale phases are reflected in the DVHs, as
shown in Fig. 7 for Patient A. The inhale differential CTV
DVH gray line indicates an overall shift in target coverage
toward lower doses compared to the exhale one black line,
including a decrease in the minimum dose to tumor from
79.0 Gy to 75.0 Gy at 84.0 Gy prescription dose to the iso-
center. For this patient most of the tumor underdosage is
due to motion. However, this is not always the case. For
patient C for example, the underdosage comes mostly from
tissue density and shape changes, as shown in Figs.
8a–8c; the minimum dose to tumor dropped from
93.1 Gy to 92.2 Gy at 98.0 Gy prescription dose.
Hot and cold spots of 20%–30% magnitude in steep dose
gradient regions surrounding the PTV were found for the
other patients as well. They led to increased normal tissue
toxicity for Patients A, B, C, and E and decreased toxicity for
Patients D and F Table IV.
C. Impact of the breathing induced motion/
deformation on the cumulative dose
While the changes in doses received at inhale compared
to exhale are quite significant, the impact of the inhale dose
distribution on the cumulative dose is diminished by the fact
that its corresponding weighting factor is 30% as it can be
seen in Fig. 9a for Patient A. As a result, the tumor cover-
age for well designed PTVs remains almost unaltered and so
does the tumors gEUD. The deviations in the ipsilateral lung
DVH are also smaller for the same reason and the effect on
the total normal lung DHV is even smaller since lungs are
parallel organs of large volume. Similar results were found
for all patients involved in the study and a summary of the
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stage exhale, at inhale and in the cumulative doses are
shown in Table IV. The comparison between the doses re-
constructed using both accumulation methods proposed
shows for this patient as well as for all patients in this study
differences less than 0.5% Fig. 9b.
For Patient B, a 5% hot spot emerged in esophagus in the
cumulative dose increasing its estimated probability of tox-
icity from 4.7% to 5.5%. Although the maximum doses were
nearly the same in both plans, the amount of dose in the
intermediate dose range led to a clear separation between
DVHs in this region as shown in Fig. 10.
IV. DISCUSSION
A. Grid size effects
While differences between the two methods proposed for
scoring dose on the planning data set exist, their magnitude
small regions of few percent is less than the changes in
dose induced by positional and shape changes from ventila-
tion and than the errors due to an increasing dose calculation
grid. Therefore, differences due solely to the interpolation
approach used to map doses from a given dataset back on the
planning dataset exhale in our study do not result in clini-
cally significant alterations in volume-based evaluation met-
rics such as mean lung dose, esophagus NTCP and tumor
equivalent uniform dose gEUD.
The choice of the grid size for dose calculation did not
have an impact on tumor coverage and mean lung doses
either, but led to erroneous estimates of the esophagus






gEUD MLD gEUD MLD gEUD
A 82.9 8.1 82.9 8.1 82.8
B 97.9 4.0 98.0 4.0 97.4
C 94.9 13.8 94.9 13.7 94.7
D 88.6 10.8 88.6 10.8 89.8
E 65.7 8.2 65.1 8.2 64.3
F 72.3 14.5 72.2 14.5 71.8
TABLE III. Summary of the inhale esophagus NTCPs % for Patient B for
the 3.5 mm, 5 mm, and 10 mm grid size when either Method 1 or Method 2
is used for interpolation.
Method 1 Method 2
Grid size mm Grid size mm
3.5 5 10 3.5 5 10
13.4 7.7 2.4 13.1 7.6 2.4Medical Physics, Vol. 32, No. 8, August 2005NTCPs for Patient B. This is because esophagus is a serial
organ and thus it is sensitive to local changes in doses, as
opposed to lungs for example for which is the mean dose that
describes the sensitivity to radiation.
The esophagus NTCP data for Patient B also suggests that
the results of Method 2 do not necessarily match the results
from Method 1 with a finer grid resolution, the reason being
that a larger calculation grid inherits erroneous voxel dose
estimation in the first place.
B. Impact of the breathing induced motion/
deformation on the cumulative dose
While the number of patients involved in this study is too
small to draw general conclusions regarding what the conse-
quences of motion/deformation are, it appears that although
motion and deformation do redistribute doses, changes are
not clinically significant. For tumors, this is a consequence of
a good PTV design. As far as the normal lung tissue is con-
cerned, motion and deformation lead to either increased or
decreased lung toxicity at inhale, but the effects on the cu-
mulative dose are small for two reasons: first, the hot/cold
spots attributed to motion/deformation that occur at inhale
are diminished by the fact that they average out in larger
inhale volumes; second, the inhale doses only have a 30%
contribution in the cumulative dose.
The situation is different for serial organs. In the example
shown in the previous section, Patient B was treated at the
maximum prescription dose allowed by an upper 5% limit in
the esophagus NTCP for late toxicity. However, the cumula-
tive dose indicated increased probability for esophagitis
above the upper bound as a result of motion/deformation.
The development of a method for dose reconstruction in a
deforming anatomy, as presented in this work represents just
one step toward implementation of 4D treatment planning.
Our results indicate that simply tracking dose grid points
between various breathing phases is a sufficiently accurate
approach, but the calculation grid size needs to be kept small
enough so that the interpolation errors are not significant.
However, the effects of motion/deformation will need to be
assessed for more patients, since the differences observed




gEUD MLD gEUD MLD gEUD MLD
82.9 8.1 82.9 8.1 82.8 8.0
97.9 4.0 98.0 4.0 97.5 3.7
94.9 13.7 95.0 13.7 94.5 13.7
89.9 10.8 88.8 10.8 88.8 10.8
65.6 8.2 64.9 8.2 63.2 8.1







14.5between the two interpolation methods may be important in
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spots in the vicinity of the tumor to lead to important
changes in target coverage as the CTV-PTV margin shrinks
and the plan becomes more conformal. Also, either the cold
FIG. 6. Patient A. a Differences at each point in space between the inhale
and the exhale dose distributions; b Changes in the inhale voxel doses due
to displacements with respect to the beam; c Overall changes in the dose
received by each exhale voxel at inhale compared to exhale.or the hot spots may become important if they happen to fall
Medical Physics, Vol. 32, No. 8, August 2005in different neighboring organs instead of canceling out in
the same organ or if they fall into a serial organ such as
spine or esophagus rather than a parallel one.
Also, the registration method used does not account for
local deformation and additional investigations are required
to assess the possible effects caused by such deformations. In
this study we have used only two breathing phases exhale
and inhale which are believed to be the most representative
due to the largest amount of time spent in this states during
one breathing cycle, but more work is needed to validate this
assumption. The recent developments in 4D imaging tech-
niques will allow for a more detailed analysis in order to
estimate the number of intermediate states required to reach
convergence in the reconstructed cumulative dose. Also, im-
TABLE IV. Mean lung doses for the exhale, inhale, and reconstructed cumu-
lative dose distributions for the 3.5 mm grid size dose calculations and using
Method 1 for dose accumulation.
Patient
Mean lung dose Gy
Exhale Inhale Cumulative
A 7.4 8.1 7.5
B 3.6 4.0 3.7
C 13.5 13.8 13.7
D 11.1 10.8 10.9
E 7.2 8.2 7.5
F 17.0 14.5 16.5
FIG. 7. Dose volume histograms for the patient shown in Fig. 5: a direct
CTV DVH and b cumulative DVH for the ipsilateral lung for exhale
black and inhale grey dose distributions.
Method 2 minus dose estimated by Method 1.
2494 Rosu et al.: Dose reconstruction in deforming lung anatomy 2494proved tumor tracking methods will allow for the derivation
of the breathing pattern for each patient and time weighting
factors could potentially be derived in each case.
In conclusion, we have implemented and investigated two
methods for dose reconstruction in the presence of motion
and deformation. The differences between the two interpola-
tion approaches appear primarily in steep dose gradient re-
gions. They are voxel size and tissue density dependent.
However, the magnitude of these differences is less than the
alterations in dose due to positional and shape changes in the
FIG. 8. Patient C. a Differences at each point in space between the inhale
and the exhale dose distributions; b Changes in the inhale voxel doses due
to displacements with respect to the beam; c Overall changes in the dose
received by each exhale voxel at inhale compared to exhale.first place. The overall changes in the cumulative dose follow
Medical Physics, Vol. 32, No. 8, August 2005FIG. 9. a Dose difference display between the cumulative dose that has
70% contribution from exhale and 30% from inhale and the exhale dose
only for Patient A; b Dose differences between the reconstructed cumula-
tive doses using refined and direct interpolation schemes dose estimated byFIG. 10. Cumulative DVH for the esophagus for exhale solid black, inhale
dotted, and cumulative solid grey dose distributions for Patient B.
2495 Rosu et al.: Dose reconstruction in deforming lung anatomy 2495the displacement of voxels with respect to the beam. The
overall effects have variability among patients, being depen-
dent on tumor location, field size, tissue heterogeneity, and
direction of tumor with respect to the beam. Large parallel
organs such as lung are likely to be less sensitive to changes
in doses emerging from motion and deformation, while in
certain cases these changes may have an impact on serial
organs such as esophagus. The method proposed is straight-
forward and can be easily implemented for any number of
intermediate states and breathing patterns.
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